SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SIBIA Neurosciences (SIBI) -- Ignore unavailable to you. Want to Upgrade?

To: John Metcalf who wrote (401)6/25/1999 10:59:00 AM
From: Mike McFarland  Read Replies (1) | Respond to of 579
 
If SIBI were to offer different terms, would
Pfizer retract or amend their complaint?

Well?
That is exactly the right question is it not?

And while I'm here--how about somebody defining
"Prior Art". My attorney wife didn't have an
answer for me last night...mumbled something about
that not being her area;-)

Another question, what happens if PFE is right--
are all these licenses going to crumble?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News